ClinicalTrials.gg
RecruitingNCT07482436Updated Mar 19, 2026

Comparison of Airway Ultrasonography and Laryngoscopy Methods in Obese Patients

An interventional study of Airway ultrasonography and Macintosh Laryngoscope Intubation in Correlation of Difficult Airway Markers With Ultrasonographic Measurements in Obese Patients, sponsored by Trabzon Kanuni Education and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-19.

Sponsored by Trabzon Kanuni Education and Research Hospital · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Jan 2026; still recruiting 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The main objective of this study was to examine the relationship between classical markers used in assessing difficult airway management in obese patients (Mallampati score, thyromental distance, sternomental distance, neck circumference measurement) and ultrasonographic parameters (vocal cord mobility, glottic opening, hyomental distance, skin-epiglottic distance, and peri-epiglottic space-epiglottic-vocal cord ratio), to compare the effects of these parameters on predicting difficult intubation, and to investigate the effects of different laryngoscopy methods on intubation success and peroperative respiratory complications.

The secondary objective of the study is to investigate the effects of different laryngoscopy methods on hemodynamic responses to intubation. Participants' gender, age, height, weight, BMI, ASA physical status classification, smoking status, comorbidities, STOP-BANG and LEMON scores will be recorded. The glottic score percentage (POGO score), glottic visualization time, endotracheal intubation time, use of assistive maneuvers, and Intubation Difficulty Scale (IDS) parameters will be compared according to the laryngoscopy methods used.

Participants must meet the following criteria:

  • Consent given by the patient
  • Operated under general anesthesia
  • Over 18 years of age
  • American Society of Anesthesiologists (ASA) physical status classification I-II-III
  • Body mass index (BMI) of 30 kg/m2 or higher
  • Operation duration between 60-150 minutes
  • Patients undergoing elective surgery.
Read the detailed description

Unanticipated morbidity related to difficult airway management remains a major concern for anesthesiologists. One of the primary reasons is the high interobserver variability and limited predictive power of currently used bedside airway assessment tests. The use of more objective and reproducible measurement techniques may improve intubation success rates and allow better preparation in cases of anticipated difficult airway.

Ultrasonography (USG) is a rapid, non-invasive, portable imaging modality that provides both static and dynamic real-time visualization. Airway ultrasonography is increasingly used in operating rooms, intensive care units, and emergency departments for detailed assessment of airway anatomy. It provides valuable information regarding upper airway structures, soft tissues of the head and neck, and pretracheal anatomy.

Preoperative airway assessment is the first and most critical step in preventing anesthesia-related airway complications. Recent evidence suggests that incorporating airway ultrasound into routine pre-anesthetic evaluation may improve the prediction of difficult airway compared to conventional clinical assessments alone.

With the global increase in obesity prevalence, anesthesiologists are encountering a growing number of obese patients in daily practice. Numerous studies have identified male sex, advanced age, increased neck circumference, higher body mass index (BMI), obstructive sleep apnea syndrome, higher Mallampati score, higher ASA score, and shorter thyromental distance as predictors of difficult intubation in obese patients. Despite these known predictors, the rate of unanticipated difficult intubation remains considerable.

Videolaryngoscopes have demonstrated high success rates in both anticipated and unanticipated difficult airway scenarios. These devices improve glottic visualization and may increase first-pass intubation success while reducing airway-related complications. In obese patients, videolaryngoscopy may further enhance intubation safety and perioperative outcomes.

This randomized prospective study aims to compare the predictive value of conventional difficult airway markers (Mallampati score, thyromental distance, sternomental distance, and neck circumference) with airway ultrasonographic parameters (vocal cord mobility, glottic opening, hyomental distance, skin-to-epiglottis distance, and peri-epiglottic space-epiglottis-vocal cord ratio) in obese patients undergoing elective surgery under general anesthesia.

Additionally, the study will evaluate the effects of three different laryngoscopy methods (Macintosh direct laryngoscope, Tuoren videolaryngoscope, and Besdata videolaryngoscope) on intubation success, perioperative respiratory complications, and hemodynamic responses. Postoperative airway ultrasonography will be performed to assess potential airway-related complications.

02

Conditions studied

  • Correlation of Difficult Airway Markers With Ultrasonographic Measurements in Obese Patients

Keywords

  • laryngoscopy
  • difficult airway
  • obese patients
  • airway ultrasonography
03

In context

Lead sponsor

Trabzon Kanuni Education and Research Hospital is the lead sponsor of 12 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who have given their consent
  • Patients who underwent surgery under general anesthesia
  • Patients over eighteen years of age
  • Patients with an (ASA) physical status classification of I-II-III
  • Patients with a (BMI) of 30 kg/m2 or higher
  • Patients whose surgery lasts between 60 and 150 minutes
  • Patients who underwent surgery under elective conditions will be included.

Exclusion criteria

Exclusion Criteria:

  • Patients who do not consent,
  • those undergoing head and neck surgery,
  • those to be operated on in the prone position,
  • uncooperative patients (patients with whom communication is not possible),
  • those with craniofacial anomalies,
  • patients operated on in emergency situations will be excluded from the study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
180 participants (estimated)

Study arms

  • Experimental
    Besdata Videolaryngoscope

    Participants randomized to this arm will undergo tracheal intubation using the Besdata videolaryngoscope under standardized general anesthesia induction.

    Procedure: Airway ultrasonography · Device: Besdata Videolaryngoscope Intubation

  • Experimental
    Tuoren Videolaryngoscope

    Participants randomized to this arm will undergo tracheal intubation using the Tuoren videolaryngoscope under standardized general anesthesia induction.

    Procedure: Airway ultrasonography · Device: Tuoren Videolaryngoscope Intubation

  • Active comparator
    Macintosh Laryngoscope

    Participants randomized to this arm will undergo tracheal intubation using a conventional Macintosh direct laryngoscope under standardized general anesthesia induction.

    Procedure: Airway ultrasonography · Device: Macintosh Laryngoscope Intubation

Interventions

  • ProcedureAirway ultrasonography

    Preoperative airway ultrasonography will be performed in the waiting area before surgery to evaluate upper airway structures including vocal cord mobility, glottic opening, hyomental distance, skin-to-epiglottis distance, and peri-epiglottic space-epiglottis-vocal cord ratio. Measurements will be obtained with a Mindray Consona N7 ultrasound device while the patient is in the supine position. Each measurement will be performed three times and the average value will be recorded. Postoperative airway ultrasonography will be repeated at 30 minutes in the recovery unit.

  • DeviceMacintosh Laryngoscope Intubation

    Endotracheal intubation will be performed using a conventional Macintosh direct laryngoscope under standardized general anesthesia induction.

  • DeviceTuoren Videolaryngoscope Intubation

    Endotracheal intubation will be performed using the Tuoren videolaryngoscope under standardized general anesthesia induction.

  • DeviceBesdata Videolaryngoscope Intubation

    Endotracheal intubation will be performed using the Besdata videolaryngoscope under standardized general anesthesia induction.

06

What researchers measure

Primary outcomes

  1. Prediction of difficult tracheal intubation

    Airway ultrasonographic parameters and conventional airway assessment scores will be evaluated to determine their ability to predict difficult tracheal intubation in obese patients undergoing elective surgery under general anesthesia. Difficult tracheal intubation will be defined using the Intubation Difficulty Scale (IDS).

    Time frame: Periprocedural (during tracheal intubation)

  2. Tracheal intubation success according to laryngoscope type

    Tracheal intubation success will be compared among patients randomized to Macintosh laryngoscope, Tuoren videolaryngoscope, and Besdata videolaryngoscope during tracheal intubation in obese patients undergoing elective surgery under general anesthesia.

    Time frame: During the tracheal intubation procedure

Secondary outcomes

  1. Glottic visualization time

    Glottic visualization time will be defined as the time from passage of the laryngoscope blade past the lips until the first visualization of the vocal cords during laryngoscopy. Glottic visualization time will be compared among the Macintosh laryngoscope, Tuoren videolaryngoscope, and Besdata videolaryngoscope groups.

    Time frame: Periprocedural (during tracheal intubation)

  2. Endotracheal intubation time

    Endotracheal intubation time will be defined as the time from passage of the laryngoscope blade past the lips until confirmation of successful tracheal intubation by capnography. Intubation time will be compared among the Macintosh laryngoscope, Tuoren videolaryngoscope, and Besdata videolaryngoscope groups.

    Time frame: Periprocedural (during tracheal intubation)

  3. Hemodynamic response to tracheal intubation

    Hemodynamic parameters will be recorded before anesthesia induction, 1 minute after induction, at 1, 3, 5, and 10 minutes after tracheal intubation, and immediately before extubation to evaluate the effects of different laryngoscopy techniques.

    Time frame: Periprocedural

  4. Postoperative airway ultrasonographic measurements

    Airway ultrasonography will be repeated 30 minutes after extubation in the recovery unit and compared with preoperative ultrasonographic measurements.

    Time frame: 30 minutes after extubation

  5. Airway-related postoperative complications

    Airway-related complications including sore throat, hoarseness, laryngospasm, bronchospasm, hypoxemia, esophageal intubation, and oral trauma will be recorded.

    Time frame: From intubation to 30 minutes postoperatively

  6. Anesthesiologist satisfaction score

    Anesthesiologist satisfaction with the laryngoscope will be evaluated using a 6-item questionnaire based on a 5-point Likert scale (1 = very poor, 5 = excellent). The questionnaire will assess the ease of laryngoscope insertion, quality of glottic visualization, ease of endotracheal tube placement, device handling, need for additional maneuvers, and overall operator satisfaction.

    Time frame: Immediately after tracheal intubation

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Sotoodehnia M, Abbasi N, Bahri RA, Abdollahi A, Baratloo A. Accuracy of airway ultrasound parameters to predict difficult airway using the LEMON criteria as a reference: A cross-sectional diagnostic accuracy study. Turk J Emerg Med. 2023 Jan 2;23(1):38-43. doi: 10.4103/2452-2473.366484. eCollection 2023 Jan-Mar. PubMed 36818949 ↗
  • Wang X, Wang Y, Zheng ZW, Liu YR, Ma WH. Ultrasound measurements for evaluation of changes in upper airway during anaesthesia induction and prediction difficult laryngoscopy: a prospective observational study. Sci Rep. 2022 Nov 3;12(1):18564. doi: 10.1038/s41598-022-21695-2. PubMed 36329088 ↗
  • Ramesh K, Srinivasan G, Bidkar PU. Comparison of Tracheal Intubation Using King Vision (Non-channeled Blade) and Tuoren Video Laryngoscopes in Patients With Cervical Spine Immobilization by Manual In-Line Stabilization: A Randomized Clinical Trial. Cureus. 2023 Aug 14;15(8):e43471. doi: 10.7759/cureus.43471. eCollection 2023 Aug. PubMed 37711910 ↗

Individual participant data

Plan to share: No — I plan to share the results after the research is complete.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2026 (actual). Primary completion is estimated for Jul 2026, 6 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2026
First posted
Mar 19, 2026
StartActual
Jan 1, 2026
Primary completionEst.
Jul 1, 2026
CompletionEst.
Jul 1, 2026
Last update
Mar 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07482436
Lead sponsor
Trabzon Kanuni Education and Research Hospital
Responsible party
Ezgi Günaydın (research assistant, Trabzon Kanuni Education and Research Hospital) — Principal investigator
First posted
Mar 19, 2026
Start date
Jan 1, 2026
Primary completion
Jul 1, 2026 (estimated)
Completion
Jul 1, 2026 (estimated)
Last update
Mar 19, 2026

Study contacts

Ezgi Günaydın, MD
Contact
ezgunaydin@gmail.com
+905336834198

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion